Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrocaps in intraoperative surgical hemostasis (FINISH-3)
NCT01527357Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- May 2012
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 3, randomised, single-blind trial of fibrinogen + thrombin in Not applicable (2 arms), sponsored by Mallinckrodt Pharmaceuticals. Primary endpoints: Time to Hemostasis for Participants Receiving Spinal Surgery at 5 minutes, Time to Hemostasis for Participants Receiving Vascular Surgery at 5 minutes and 2 more. Started May 2012; status: completed.
02
Drugs
fibrinogen + thrombin
03
Conditions
Not applicable
Beyond the preview
Go deeper on NCT01527357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527357.